Delivery Order SPE2DB24D2100-SPE2DB25FBEUC
- Not listed
- The Defense Logistics Agency awarded a $1,161.18 delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Estrogen-Methyltestosterone tablets (100 count). This firm fixed price contract, with an ultimate completion date of August 7, 2025, represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The contract was competitively awarded with no set-aside designation and will be performed at the...
- The Defense Logistics Agency awarded a delivery order valued at $1,454.40 to AmerisourceBergen Drug Corp for Estrogen-Methyltestosterone tablets (100 count) on August 20, 2025, with an ultimate completion date of August 21, 2025. This competitively awarded, firm fixed price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a single transaction under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,584.51 to AmerisourceBergen Drug Corp for the supply of Estrogen-Methyltestosterone tablets (100 count) on April 24, 2025, with completion scheduled for April 25, 2025. This non-set-aside contract represents a firm fixed price delivery order executed under competitive procurement procedures. The award leverages AmerisourceBergen's extensive pharmaceutical distribution capabilities and established relationship with the Defense...
- The Defense Logistics Agency awarded a delivery order valued at $1,317.41 to AmerisourceBergen Drug Corp for Estrogen-Methyltestosterone tablets (100-count) with a firm fixed price structure. This non-set-aside contract was awarded on August 19, 2025, with an ultimate completion date of August 20, 2025. The place of performance is AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $1,940.50 firm fixed-price delivery order to AmerisourceBergen Drug Corp for estrogen-methyltestosterone tablets (100-count) on September 25, 2025, with completion scheduled for September 26, 2025. This non-set-aside contract was competitively awarded to the major pharmaceutical distributor and reflects routine medical supply procurement for military healthcare needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Estrogen-Methyltestos F.S. Tablets, 100 count, with a ceiling value of $1,805.32 and a period of performance through May 19, 2025. The contract is a firm fixed-price delivery order and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a larger Indefinite...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,690.73, is for the delivery of Estrogen-Methyltestos F.S. Tab 100s, a medical product. The contract has a firm fixed price pricing type and an ultimate completion date of October 28, 2024. Amerisourcebergen Drug Corp is a for-profit organization registered in the System for Award Management (SAM.gov)...
- This federal contract award, valued at $1,318.53, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ESTROGEN-METHYLTESTOS F.S. TAB 100S, a medical product, and has an ultimate completion date of June 28, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type, and there is no set-aside designation indicated. Amerisourcebergen holds a...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of Estrogen-Methyltestosterone Hydrochloride Succinate Tablets, 100s. The contract has a ceiling value of $1,675.69 and an ultimate completion date of August 7, 2024. The delivery order is a firm fixed price contract and is not set aside for any specific business designation. AmerisourceBergen, a major pharmaceutical distributor, has been awarded multiple indefinite...
- The Defense Logistics Agency awarded a $492,630 delivery order to Amerisourcebergen Drug Corporation for the purchase of 100 boxes of Estrogen-Methyltestos H.S. tablets. The contract has a firm fixed price and will be performed by Amerisourcebergen in Conshohocken, Pennsylvania over a period of one day, from August 21, 2023 to August 22, 2023. No major subcontractors or set aside designations were identified. The Defense Logistics Agency manages the global supply chain for the United States...
- SPE2DB24D2100Indefinite Delivery Contract
- SPE2DB24D2100-SPE2DB25FBEUCDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 17, 2025, for the supply of Estrogen-Methyltestosterone tablets (100 count) with a ceiling value of $3,170.48. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under open competition. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of June 18, 2025. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. As a prime pharmaceutical vendor, AmerisourceBergen supplies a comprehensive range of medications and medical commodities to support military and federal healthcare systems globally. The company's federal contract portfolio demonstrates consistent capability to fulfill diverse pharmaceutical procurement requirements, including specialty medications, vaccines, and medical devices across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.2k | 6/17/25 |